Diagnostic Imaging

Given Imaging's M2A to be reimbursed by Regence Group

Published in Cancer Weekly, December 24th, 2002

Given Imaging, Inc., (GIVN) announced that The Regence Group has initiated reimbursement coverage of capsule endoscopy for the small intestine.

Regence, through its Blue Cross and Blue Shield affiliates in Oregon, Washington, Utah, and Idaho provide healthcare coverage to more than 3 million members.

Regence will offer capsule endoscopy reimbursement to those among its beneficiaries who may suffer from disorders associated with gastrointestinal bleeding from sources unidentified by other diagnostic methods. This brings to 38 million the total number of patients in the United States who currently have reimbursable access to the M2A diagnostic system...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-12-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry